Literature DB >> 17401647

Distribution of immunoreactive prolyl oligopeptidase in human and rat brain.

Timo T Myöhänen1, Jarkko I Venäläinen, Erkki Tupala, J Arturo Garcia-Horsman, Riitta Miettinen, Pekka T Männistö.   

Abstract

Prolyl oligopeptidase (POP) is a serine endoprotease that hydrolyses peptides shorter than 30-mer. POP may have a role in inositol 1,4,5-triphosphate (IP(3)) signaling and in the actions of antidepressants, and POP inhibitors have exhibited antiamnesic and neuroprotective properties. However, little is known about the distribution of POP protein in the brain. We used immunohistochemistry to localize POP enzyme in the human whole hemisphere and in the rat whole brain. In humans, the highest POP densities were observed in caudate nucleus and putamen, hippocampus and cortex. In the rat, the highest POP densities were found in substantia nigra, hippocampus, cerebellum and caudate putamen. In general, the distribution of POP in human and rat brains was very similar and resembled that of IP(3) receptors. Our findings are support for a role of POP in movement regulation, cognition and possibly in IP(3) signaling. The expression of POP in processing nuclei further supports its function beyond neuropeptide metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17401647     DOI: 10.1007/s11064-007-9316-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  40 in total

1.  Effects of environmental enrichment on gene expression in the brain.

Authors:  C Rampon; C H Jiang; H Dong; Y P Tang; D J Lockhart; P G Schultz; J Z Tsien; Y Hu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Effect of a novel prolyl endopeptidase inhibitor, JTP-4819, on neuropeptide metabolism in the rat brain.

Authors:  K Toide; T Fujiwara; Y Iwamoto; M Shinoda; K Okamiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

Review 3.  On the role of prolyl oligopeptidase in health and disease.

Authors:  J A García-Horsman; P T Männistö; J I Venäläinen
Journal:  Neuropeptides       Date:  2006-12-29       Impact factor: 3.286

4.  Distribution of prolyl endopeptidase activities in rat and human brain.

Authors:  Jon Irazusta; Gorka Larrinaga; Javier González-Maeso; Javier Gil; J Javier Meana; Luis Casis
Journal:  Neurochem Int       Date:  2002-04       Impact factor: 3.921

Review 5.  Cortical association areas in the gustatory system.

Authors:  T V Sewards; M A Sewards
Journal:  Neurosci Biobehav Rev       Date:  2001-07       Impact factor: 8.989

6.  Regulation of prolyl oligopeptidase activity in regenerating rat liver.

Authors:  N Yamakawa; H Shimeno; S Soeda; A Nagamatsu
Journal:  Biochim Biophys Acta       Date:  1994-04-21

Review 7.  S 17092: a prolyl endopeptidase inhibitor as a potential therapeutic drug for memory impairment. Preclinical and clinical studies.

Authors:  Philippe Morain; Pierre Lestage; Guillaume De Nanteuil; Roeline Jochemsen; Jean-Loïc Robin; David Guez; Pierre-Alain Boyer
Journal:  CNS Drug Rev       Date:  2002

8.  Evidence for the presence of prolyl oligopeptidase and its endogenous inhibitor in neonatal rat pancreatic beta-cells.

Authors:  P Salers
Journal:  Regul Pept       Date:  1994-03-17

Review 9.  The role of neuropeptides in learning: focus on the neurokinin substance P.

Authors:  J P Huston; R U Hasenöhrl
Journal:  Behav Brain Res       Date:  1995-01-23       Impact factor: 3.332

10.  Comparison of proline endopeptidase activity in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.

Authors:  D Mantle; G Falkous; S Ishiura; P J Blanchard; E K Perry
Journal:  Clin Chim Acta       Date:  1996-05-30       Impact factor: 3.786

View more
  18 in total

1.  Different interactions of prolyl oligopeptidase and neurotensin in dopaminergic function of the rat nigrostriatal and mesolimbic pathways.

Authors:  I Peltonen; T T Myöhänen; P T Männistö
Journal:  Neurochem Res       Date:  2012-06-23       Impact factor: 3.996

2.  Tetrazole as a Replacement of the Electrophilic Group in Characteristic Prolyl Oligopeptidase Inhibitors.

Authors:  Tommi P Kilpeläinen; Jonna K Tyni; Maija K Lahtela-Kakkonen; Tony S Eteläinen; Timo T Myöhänen; Erik A A Wallén
Journal:  ACS Med Chem Lett       Date:  2019-11-11       Impact factor: 4.345

3.  A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease.

Authors:  T T Myöhänen; M J Hannula; R Van Elzen; M Gerard; P Van Der Veken; J A García-Horsman; V Baekelandt; P T Männistö; A M Lambeir
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

4.  Prolyl endopeptidase-deficient mice have reduced synaptic spine density in the CA1 region of the hippocampus, impaired LTP, and spatial learning and memory.

Authors:  Giuseppe D'Agostino; Jung Dae Kim; Zhong-Wu Liu; Jin Kwon Jeong; Shigetomo Suyama; Antonio Calignano; Xiao-Bing Gao; Michael Schwartz; Sabrina Diano
Journal:  Cereb Cortex       Date:  2012-07-05       Impact factor: 5.357

5.  Localization and subcellular distribution of prolyl oligopeptidase in the mouse placenta.

Authors:  Shin Matsubara; Takayuki Takahashi; Atsushi P Kimura
Journal:  J Mol Histol       Date:  2011-05-05       Impact factor: 2.611

6.  Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.

Authors:  Jofre Tenorio-Laranga; Francisco Coret-Ferrer; Buenaventura Casanova-Estruch; María Burgal; J Arturo García-Horsman
Journal:  J Neuroinflammation       Date:  2010-04-06       Impact factor: 8.322

7.  Distribution of prolyl oligopeptidase in human peripheral tissues and in ovarian and colorectal tumors.

Authors:  Timo T Myöhänen; Elisa Pyykkö; Pekka T Männistö; Olli Carpen
Journal:  J Histochem Cytochem       Date:  2012-06-26       Impact factor: 2.479

8.  The beneficial effect of a prolyl oligopeptidase inhibitor, KYP-2047, on alpha-synuclein clearance and autophagy in A30P transgenic mouse.

Authors:  Mari H Savolainen; Christopher T Richie; Brandon K Harvey; Pekka T Männistö; Kathleen A Maguire-Zeiss; Timo T Myöhänen
Journal:  Neurobiol Dis       Date:  2014-04-16       Impact factor: 5.996

9.  Distribution of prolyl oligopeptidase in the mouse whole-body sections and peripheral tissues.

Authors:  Timo T Myöhänen; Jarkko I Venäläinen; J Arturo García-Horsman; Marjo Piltonen; Pekka T Männistö
Journal:  Histochem Cell Biol       Date:  2008-07-11       Impact factor: 4.304

Review 10.  Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.

Authors:  Timo T Myöhänen; J Arturo García-Horsman; Jofre Tenorio-Laranga; Pekka T Männistö
Journal:  J Histochem Cytochem       Date:  2009-05-26       Impact factor: 2.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.